Trials / Unknown
UnknownNCT05103813
Protective Effect of Beraprost Sodium Tablets on Reperfusion Therapy for Acute STEMI
Protective Effect of Beraprost Sodium Tablets on Coronary Microcirculation Function and Ventricular Remodeling After Reperfusion Therapy for Acute ST Segment Elevation Myocardial Infarction
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Shenzhen People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Protective effect of Beraprost Sodium Tablets on coronary microcirculation function and ventricular remodeling after reperfusion therapy for acute ST segment elevation myocardial infarction
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Beraprost Sodium Tablets | Protective effect of Beraprost Sodium Tablets on coronary microcirculation function and ventricular remodeling after reperfusion therapy for acute ST segment elevation myocardial infarction |
Timeline
- Start date
- 2022-05-01
- Primary completion
- 2022-12-31
- Completion
- 2023-06-30
- First posted
- 2021-11-02
- Last updated
- 2022-02-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05103813. Inclusion in this directory is not an endorsement.